Making use of the Internet to increase, as much as possible,
the number of people who can live longer and healthier lives,
and to reduce, as much as possible, the amount of unnecessary medical costs
this is both the desire and goal of M3.
Investor Relations
2025/08/06
Investor Relations
[FY2025 Q1] Summary of Consolidated Financial Results
2025/08/06
Investor Relations
[FY2025 Q1] M3 Presentation Material
2025/08/06
Investor Relations
VIDAL Group acquires GPR, providing prescription support tool for renal failure in France
2025/08/06
Investor Relations
Notice Concerning Grant of Stock Options (Share Acquisition Rights)
2025/08/06
Investor Relations
Notice Regarding the Status of Repurchase of Own Shares (Repurchase of Shares Under the Provision of M3’s Articles of Incorporation Pursuant to Article 459, Paragraph 1 of the Companies Act)
2025/07/07
Investor Relations
Notice Regarding the Status of Repurchase of Own Shares (Repurchase of Shares Under the Provision of M3’s Articles of Incorporation Pursuant to Article 459, Paragraph 1 of the Companies Act)
2025/06/06
Investor Relations
Matters Related to Controlling Shareholders, etc.
2025/06/06
Investor Relations
Notice Regarding the Status of Repurchase of Own Shares (Repurchase of Shares Under the Provision of M3’s Articles of Incorporation Pursuant to Article 459, Paragraph 1 of the Companies Act)
2025/06/03
Investor Relations
NOTICE OF 2025 ORDINARY GENERAL MEETING OF SHAREHOLDERS
2025/05/02
Investor Relations
[FY2024 Q4] Summary of Consolidated Financial Results
